AI assistant
Sending…
Luye Pharma Group Limited — Earnings Release 2002
Jul 17, 2002
50431_rns_2002-07-17_b4dfa927-9ad7-46df-b262-4fc3ea6266a2.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
![]() |
| TAKSON HOLDINGS<00918> - Results Announcement Takson Holdings Limited announced on 17/07/2002: (stock code: 00918 ) Year end date: 31/03/2002 Currency: HKD Auditors' Report: Unqualified Review of Interim Report by: (Audited ) (Audited ) Last Current Corresponding Period Period from 01/04/2001 from 01/04/2000 to 31/03/2002 to 31/03/2001 Note ('000 ) ('000 ) Turnover : 238,564 514,357 Profit/(Loss) from Operations : (30,046) (54,692) Finance cost : (4,469) (13,561) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : 150 (1,321) Profit/(Loss) after Tax & MI : (33,892) (69,836) % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : (0.086) (0.182) -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (33,892) (69,836) Final Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: Notes: (1) Loss from operations Loss from operations is stated after charging the following: 2002 2001 HK$000 HK$000 Impairment loss on leasehold land and buildings - (35,620) Provision for loss on down materials - (16,588) Write-off of/provision for loss on textile quota deposits (18,896) (18,756) ======== ======== (2) Loss per share The calculation of basic loss per share is based on the Group's loss attributable to shareholders of HK$33,892,000 (2001: loss of HK$69,836,000). The basic loss per share is based on the weighted average number of 392,924,658 (2001: 384,743,014) ordinary shares in issue during the year. No diluted loss per share is presented for the years ended 31st March, 2002 and 2001 as there is no dilutive potential ordinary share for the year ended 31st March, 2002 and the exercise of share options has an anti-dilutive effect for the year ended 31st March, 2001. |
More from Luye Pharma Group Limited
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 29
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Earnings Release
2026
Mar 31
Report Publication Announcement
2026
Mar 17
Regulatory Filings
2026
Mar 5
Share Issue/Capital Change
2026
Feb 5
